NCT03477734View on ClinicalTrials.gov

Performance and Efficacy of the CardiacSense1 for Detection of Atrial Fibrillation

NACompletedINTERVENTIONAL
Enrollment

53

Participants

Timeline

Start Date

February 20, 2019

Primary Completion Date

November 25, 2019

Study Completion Date

June 9, 2020

Conditions
Atrium; Fibrillation
Interventions
DEVICE

CS1 & heart monitor

Daily activities while wearing the investigational device as well as the control device

Trial Locations (2)

62431

Sourasky Medical Center, Tel Aviv

Unknown

Rambam Medical Center, Haifa

All Listed Sponsors
lead

CardiacSense Ltd.

INDUSTRY

NCT03477734 - Performance and Efficacy of the CardiacSense1 for Detection of Atrial Fibrillation | Biotech Hunter | Biotech Hunter